Jennison Associates’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-114,369
| Closed | -$6.8M | – | 665 |
|
|
2020
Q3 | $6.8M | Buy |
114,369
+1,907
| +2% | +$113K | 0.01% | 409 |
|
|
2020
Q2 | $7.85M | Sell |
112,462
-25,232
| -18% | -$1.76M | 0.01% | 399 |
|
|
2020
Q1 | $6.25M | Buy |
137,694
+6,317
| +5% | +$287K | 0.01% | 374 |
|
|
2019
Q4 | $8.55M | Sell |
131,377
-2,408
| -2% | -$157K | 0.01% | 392 |
|
|
2019
Q3 | $8.31M | Sell |
133,785
-203,369
| -60% | -$12.6M | 0.01% | 422 |
|
|
2019
Q2 | $24M | Sell |
337,154
-18,807
| -5% | -$1.34M | 0.02% | 317 |
|
|
2019
Q1 | $27.9M | Buy |
355,961
+47,917
| +16% | +$3.76M | 0.03% | 303 |
|
|
2018
Q4 | $26.1M | Buy |
+308,044
| New | +$26.1M | 0.03% | 311 |
|